Skip to main content
. 2019 Feb 24;10(1):24–33. doi: 10.14740/cr813

Figure 7.

Figure 7

Adverse events (AEs) in sacubitril/valsartan-treated patients vs. ARB-treated controls. (a) In the control group olmesartan was used as comparator. (b) In the control group valsartan was used as comparator. pts: patients; ctrl: controls; ARBs: angiotensin receptor blockers; CI: confidence interval.